Dermalyser Secures CE Mark, Revolutionizing Melanoma Detection in Europe AI Medical Technology's Dermalyser achieves CE mark approval in Europe, enhancing the detection of melanoma through innovative AI technology.

Dermalyser Secures CE Mark, Revolutionizing Melanoma Detection in Europe #Sweden #Stockholm #Dermalyser #AI_Medical_Technology #melanoma_detection